用于基因和RNA疗法的红细胞衍生细胞外囊:生物学,工程和翻译挑战
Tayyab Shafiq1,2,3, Nawaz Khan1,2,3, Tehreem Kausar1,2,3
1School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, People's Republic of China.
International journal of nanomedicine
|February 27, 2026
概括
红细胞细胞外囊泡 (RBC-EVs) 为基因治疗提供了一个有希望的,低免疫性平台. 红细胞-EV的创新提高了治疗遗传疾病,炎症和癌症的精度.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 基因疗法面临临的临床障碍是由于免疫性和弱准.
- 目前的输送方法可能会导致全身毒性和不良影响.
研究的目的:
- 审查最近使用红细胞细胞外囊泡 (RBC-EVs) 进行mRNA和CRISPR-Cas传递的进展.
- 突出RBC-EV作为下一代准确医学平台.
主要方法:
- 在RBC-EVs中封装mRNA和CRISPR-Cas组件.
- 纳入刺激敏感释放和组织选择性向策略.
- 审查最近的发展和RBC-EVs的潜在应用.
主要成果:
- 红细胞-EV显示生物相容性,稳定性和低免疫性.
- RBC-EV能够准确,时间和空间特定的传送治疗货物.
- 增强的红细胞-EV可以克服当前基因治疗载体的局限性.
结论:
- 红细胞-EVs为mRNA和CRISPR-Cas代理提供了一个强大的输送平台.
- 这些囊泡提供免疫逃避,可扩展性和通用载荷能力.
- 红细胞-EV具有显著的潜力,可以推进精密医学和基因疗法应用.
相关概念视频
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K


